Jeffrey Katz is a Rheumatology/Immunology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Brigham And Womens Hospital
Div Of Rheumatology Immunology And Allergy
Boston, MA 02115
Telephone
617-732-5338Registry record last updated 2 Jul 2012.
Clinical trials
- Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Sponsor: Northwell Health
- Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20221 payment$13,594openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
61.8%Gabapentinoids25.7%Gabapentin72%Pregabalin28%Part D<11 patientsOpioid Agonist25.7%Oxycodone Hcl73%Tramadol Hcl27%Part D<11 patients+ 1 more class in this area
Cancer & immunology
21.7%Folate Analog Metabolic Inhibitor16.9%Methotrexate100%Part D≥11 patientsTNF inhibitor4.8%Enbrel Sureclick100%Part D<11 patientsOther
10.8%Folate Analog10.8%Leucovorin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
12 NIH research awards on record, funded 1995–2024 per NIH RePORTER. The latest:
- Surgery vs. conservative care for meniscal tear after unsuccessful PT: an RCT
Brigham and Women'S Hospital
FY2024$225,529R34AR082021 - PARTIAL MENISCECTOMY VS. NONOPERATIVE MGMT. IN MENISCAL TEAR WITH OA: AN RCT
Brigham and Women'S Hospital
FY2023$544,142R01AR055557 - Clinical Orthopaedic and Musculoskeletal Education and Training Program (COMET)
Brigham and Women'S Hospital
FY2023$303,804T32AR055885
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”